Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Inflammation in the pathophysiology of essential hypertension Montecucco F; Pende A; Quercioli A; Mach FJ Nephrol 2011[Jan]; 24 (1): 23-34In spite of the huge amount of research recently performed in this area, the pathogenesis of human hypertension remains elusive. Thus, hypertension has to be defined as "essential" for the majority of patients with high blood pressure. Given the lack of animal models useful to investigate essential hypertension, we analyze and discuss both clinical and basic research studies indicating that essential hypertension should be considered as a potential multifactorial inflammatory disease. The pathophysiology of essential hypertension might result from interactions between genetic and environmental factors. Morphological abnormalities in the renal parenchyma and arteries have also been shown to determine hypertension. Inflammatory processes might induce renal vasoconstriction, ischemia and injury that can sustain systemic hypertension. Arterial and tubulointerstitial infiltration of inflammatory cells in response to renal damage might further increase renal and vascular alterations through the production of oxidants and other soluble inflammatory mediators. The present review gives an update regarding the latest research on the possible direct role of inflammation in the pathophysiology of essential hypertension.|*Blood Pressure/drug effects[MESH]|Animals[MESH]|Anti-Inflammatory Agents/therapeutic use[MESH]|Antihypertensive Agents/therapeutic use[MESH]|Female[MESH]|Humans[MESH]|Hypertension/drug therapy/*immunology/physiopathology[MESH]|Inflammation Mediators/*metabolism[MESH]|Inflammation/drug therapy/*immunology/physiopathology[MESH]|Male[MESH]|Renin-Angiotensin System[MESH]|Risk Assessment[MESH]|Risk Factors[MESH] |